ORCID as entered in ROS

Select Publications
2025, 'Asymmetrical glymphatic dysfunction in patients with long Covid associated neurocognitive impairment- correlation with BBB disruption', BMC Neurology, 25, http://dx.doi.org/10.1186/s12883-025-04133-4
,2025, 'Neuropathogenesis of acute HIV: mechanisms, biomarkers, and therapeutic approaches', Current Opinion in HIV and AIDS, 20, pp. 199 - 208, http://dx.doi.org/10.1097/COH.0000000000000923
,2025, 'Brain RNA profiling highlights multiple disease pathways in persons with HIV-associated neurocognitive disorder', AIDS, 39, pp. 496 - 507, http://dx.doi.org/10.1097/QAD.0000000000004116
,2025, 'Deferiprone in Alzheimer Disease: A Randomized Clinical Trial', JAMA Neurology, 82, pp. 11 - 18, http://dx.doi.org/10.1001/jamaneurol.2024.3733
,2025, 'Altered blood-brain barrier permeability is associated with abnormal distant connectivity and regional homogeneity in covert hepatic encephalopathy - a cross sectional study', Hepatology, http://dx.doi.org/10.1097/HEP.0000000000001343
,2025, 'Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial', Journal of Prevention of Alzheimer S Disease, 12, pp. 100016, http://dx.doi.org/10.1016/j.tjpad.2024.100016
,2025, 'Cerebellar stroke secondary to ovarian stimulation and patent foramen ovale', Internal Medicine Journal, 55, pp. 167 - 168, http://dx.doi.org/10.1111/imj.16622
,2025, 'Fostering healthy cognitive ageing in people living with HIV', Lancet HIV, 12, pp. e71 - e80, http://dx.doi.org/10.1016/S2352-3018(24)00248-0
,2025, 'Neuroinflammation associated with proviral DNA persists in the brain of virally suppressed people with HIV.', Front Immunol, 16, pp. 1570692, http://dx.doi.org/10.3389/fimmu.2025.1570692
,2024, 'Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-47720-8
,2024, 'Visualization of incrementally learned projection trajectories for longitudinal data', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-024-63511-z
,2024, 'Activation of the kynurenine pathway identified in individuals with covert hepatic encephalopathy', Hepatology Communications, 8, http://dx.doi.org/10.1097/HC9.0000000000000559
,2024, 'The roles of the kynurenine pathway in COVID-19 neuropathogenesis', Infection, 52, pp. 2043 - 2059, http://dx.doi.org/10.1007/s15010-024-02293-y
,2024, 'HIV transcription persists in the brain of virally suppressed people with HIV', Plos Pathogens, 20, http://dx.doi.org/10.1371/journal.ppat.1012446
,2024, 'Plasma neurofilament light chain protein predicts greater brain-age gap, cognition, and cardiovascular risk in people with HIV', AIDS, 38, pp. 1081 - 1083, http://dx.doi.org/10.1097/QAD.0000000000003880
,2024, 'Cognitive criteria in HIV: greater consensus is needed', Nature Reviews Neurology, 20, pp. 127 - 128, http://dx.doi.org/10.1038/s41582-024-00927-1
,2024, 'A Review of the Evidence for Tryptophan and the Kynurenine Pathway as a Regulator of Stem Cell Niches in Health and Disease', International Journal of Tryptophan Research, 17, pp. 11786469241248287, http://dx.doi.org/10.1177/11786469241248287
,2024, 'Blood brain barrier disruption and glutamatergic excitotoxicity in post-acute sequelae of SARS COV-2 infection cognitive impairment: potential biomarkers and a window into pathogenesis', Frontiers in Neurology, 15, http://dx.doi.org/10.3389/fneur.2024.1350848
,2024, 'PROGRESS‐AD: a phase 2 study to evaluate efficacy and safety of GSK4527226 (AL101), an anti‐sortilin monoclonal antibody, in patients with early Alzheimer’s disease', Alzheimer's & Dementia, 20, http://dx.doi.org/10.1002/alz.090247
,2023, 'Antiretroviral therapy intensification for HIV-associated neurocognitive disorder?', AIDS, 37, pp. 2095 - 2096, http://dx.doi.org/10.1097/QAD.0000000000003694
,2023, 'Treatable traits for long COVID', Respirology, 28, pp. 1005 - 1022, http://dx.doi.org/10.1111/resp.14596
,2023, 'Regional Analysis of Intact and Defective HIV Proviruses in the Brain of Viremic and Virally Suppressed People with HIV', Annals of Neurology, 94, pp. 798 - 802, http://dx.doi.org/10.1002/ana.26750
,2023, 'Reversible large-scale network disruption correlates with neurocognitive improvement in HIV-associated minor neurocognitive disorder with combined anti-retroviral therapy intensification: a prospective longitudinal resting-state functional magnetic resonance imaging study', Neurological Sciences, 44, pp. 3261 - 3269, http://dx.doi.org/10.1007/s10072-023-06783-z
,2023, 'Retraction Note to: Changes in Cathepsin D and Beclin-1 mRNA and protein expression by the excitotoxin quinolinic acid in human astrocytes and neurons (Metabolic Brain Disease, (2014), 29, 3, (873-883), 10.1007/s11011-014-9557-9)', Metabolic Brain Disease, 38, pp. 2197, http://dx.doi.org/10.1007/s11011-023-01241-3
,2023, 'The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC', Annals of Clinical and Translational Neurology, 10, pp. 1338 - 1352, http://dx.doi.org/10.1002/acn3.51825
,2023, 'Statement in Support of: "Virology under the Microscope - a Call for Rational Discourse"', Msphere, 8, http://dx.doi.org/10.1128/msphere.00165-23
,2023, 'Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”', Mbio, 14, http://dx.doi.org/10.1128/mbio.00815-23
,2023, 'Assessing preparedness for Alzheimer disease-modifying therapies in Australasian health care systems', Medical Journal of Australia, 218, pp. 247 - 249, http://dx.doi.org/10.5694/mja2.51880
,2023, 'Extracellular vesicle small noncoding RNAs: A window into pathogenesis and diagnosis', AIDS, 37, pp. 849 - 850, http://dx.doi.org/10.1097/QAD.0000000000003517
,2023, 'Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study', Journal of Neurovirology, 29, pp. 141 - 155, http://dx.doi.org/10.1007/s13365-022-01104-0
,2023, 'Novel magnetic resonance KTRANS measurement of blood-brain barrier permeability correlated with covert HE', Hepatology Communications, 7, http://dx.doi.org/10.1097/HC9.0000000000000079
,2023, 'Validity of serum neurofilament light chain as a prognostic biomarker of disease activity in multiple sclerosis', Journal of Neurology, 270, pp. 1908 - 1930, http://dx.doi.org/10.1007/s00415-022-11507-y
,2023, 'Cognitive Health in Persons with Human Immunodeficiency Virus: The Impact of Early Treatment, Comorbidities, and Aging', Journal of Infectious Diseases, 227, pp. S38 - S47, http://dx.doi.org/10.1093/infdis/jiac388
,2023, 'Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaques', Plos Pathogens, 19, http://dx.doi.org/10.1371/journal.ppat.1011290
,2023, 'Is neurocognitive ageing accelerated in virally suppressed people with HIV and multimorbidity?', Brain, 146, pp. 801 - 802, http://dx.doi.org/10.1093/brain/awad035
,2023, 'New Detection of Locally Acquired Japanese Encephalitis Virus Using Clinical Metagenomics, New South Wales, Australia', Emerging Infectious Diseases, 29, pp. 627 - 630, http://dx.doi.org/10.3201/eid2903.220632
,2023, 'Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study', BRAIN, 146, pp. 2275 - 2284, http://dx.doi.org/10.1093/brain/awad024
,2023, 'Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not', Eclinicalmedicine, 56, pp. 101792, http://dx.doi.org/10.1016/j.eclinm.2022.101792
,2023, 'Current Challenges and Solutions for Clinical Management and Care of People with HIV: Findings from the 12th Annual International HIV and Aging Workshop', AIDS Research and Human Retroviruses, 39, pp. 1 - 12, http://dx.doi.org/10.1089/aid.2022.0079
,2023, 'Statement in Support of: “Virology under the Microscope-a Call for Rational Discourse”', Journal of Virology, 97, http://dx.doi.org/10.1128/jvi.00451-23
,2023, 'The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment', Frontiers in Cellular Neuroscience, 17, http://dx.doi.org/10.3389/fncel.2023.1130938
,2023, '42 White matter injury is driven by HIV duration, immune and vascular factors in virally suppressed people living with HIV: a longitudinal diffusion imaging study', Journal of the International Neuropsychological Society, 29, pp. 915 - 916, http://dx.doi.org/10.1017/s1355617723011244
,2023, 'Activation of the kynurenine pathway potentially underlies neurodegeneration in patients with covert hepatic encephalopathy', JOURNAL OF HEPATOLOGY, 78, pp. S263 - S264
,2022, 'Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection (BMC Neurology, (2021), 21, 1, (494), 10.1186/s12883-021-02527-8)', BMC Neurology, 22, http://dx.doi.org/10.1186/s12883-022-02725-y
,2022, 'Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury', Proceedings of the National Academy of Sciences of the United States of America, 119, pp. 1 - 11, http://dx.doi.org/10.1073/pnas.2210584119
,2022, 'Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART', Annals of Neurology, 92, pp. 532 - 544, http://dx.doi.org/10.1002/ana.26456
,2022, 'The relationship between the epigenetic aging biomarker “grimage” and lung function in both the airway and blood of people living with HIV: An observational cohort study', Ebiomedicine, 83, http://dx.doi.org/10.1016/j.ebiom.2022.104206
,2022, 'Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study', Clinical Infectious Diseases, 75, pp. 493 - 502, http://dx.doi.org/10.1093/cid/ciab943
,2022, 'Recent advances in clinical trials targeting the kynurenine pathway', Pharmacology and Therapeutics, 236, http://dx.doi.org/10.1016/j.pharmthera.2021.108055
,2022, 'Abnormal cognitive aging in people with HIV: evidence from data integration between two countries’ cohort studies', AIDS, 36, pp. 1171 - 1179, http://dx.doi.org/10.1097/QAD.0000000000003230
,